Drug Type Small molecule drug |
Synonyms Ketoconazole/desonide, Seboride |
Target |
Action inhibitors, agonists |
Mechanism CYP51A1 inhibitors(Cytochrome P450 51 inhibitors), GR agonists(Glucocorticoid receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC24H32O6 |
InChIKeyWBGKWQHBNHJJPZ-LECWWXJVSA-N |
CAS Registry638-94-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dermatitis, Seborrheic | Phase 3 | United States | - | - |
Dermatitis, Seborrheic | Phase 3 | Belgium | - | - |
Dermatitis, Seborrheic | Phase 3 | - | - | |
Dermatitis, Seborrheic | Phase 3 | Poland | - | - |